As of May 25
| +0.15 / +1.27%|
The 6 analysts offering 12-month price forecasts for Insmed Inc have a median target of 23.00, with a high estimate of 25.00 and a low estimate of 13.00. The median estimate represents a +92.31% increase from the last price of 11.96.
The current consensus among 6 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.